Intensive management of diabetes pays fewer dividends as patients age and raises the chances of hypoglycemia. But many people ...

Like Aly, Abdul-Rahman also stresses that GLP-1 medications are a treatment for diabetes and obesity, and as such, they do ...

Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.

For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION).

Indian drug companies are set to revolutionize diabetes treatment with affordable generic versions of Empagliflozin, ...